Celldex Therapeutics reported $-56600000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
AbbVie USD 938M 348M Jun/2025
Amgen USD 1.43B 298M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Celldex Therapeutics USD -56600000 2.8M Jun/2025
Glaxosmithkline GBP 1.44B 1.03B Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024